Title: 1 A RESOLUTION encouraging the Kentucky Department for Public Health, in
Official Title: 1 A RESOLUTION encouraging the Kentucky Department for Public Health, in
Number of Sections: 1
Source: versions - Introduced
Media Type: application/pdf
Strikethrough Detection: 2 sections found

================================================================================

Section 1:
UNOFFICIAL COPY 25 RS BR 2025
2 conjunction with the Kentucky Office of Drug Control Policy, to issue a public statement
3 to increase awareness in the Commonwealth on the potential harm of consuming 7-
4 hydroxymitragynine products.
5 WHEREAS, kratom contains two main chemical compounds, mitragynine and 7-
6 hydroyxmitragynine, both of which bind to the same receptors in the brain as opioid
7 drugs such as codeine; and
8 WHEREAS, mitragynine is naturally present in kratom in much higher quantities
9 than 7-hydroxymitragynine; and
10 WHEREAS, 7-hydroxymitragynine is a terpenoid indole alkaloid that acts on the
11 brain’s opioid receptors; and
12 WHEREAS, according to the United States Food and Drug Administration, 7-
13 hydroxymitragynine may produce classic opioid-related effects including sedation,
14 nausea and vomiting, physical dependence and withdrawals, and respiratory depression;
15 and
16 WHEREAS, 7-hydroxymitragynine is an addictive substance; and
17 WHEREAS, food chemists have developed techniques to synthesize 7-
18 hydroxymitragynine from mitragynine allowing the artificial increase in the levels of 7-
19 hydroxymitragynine in kratom products; and
20 WHEREAS, according to a study published in the Addiction Biology Journal, the
21 consumption of 7-hydroxymitragynine can lead to an increased utilization of other
22 opioids including morphine; and
23 WHEREAS, the analgesic properties of 7-hydroxymitragynine are 13 times greater
24 than morphine; and
25 WHEREAS, there are companies marketing products labeled as kratom that may
26 primarily contain the more potent synthetic product called 7-hydroxmitragynine;
27 NOW, THEREFORE,
Page 1 of 2
XXXX 3/12/2025 7:15 PM Jacketed
UNOFFICIAL COPY 25 RS BR 2025
1 Be it resolved by the House of Representatives of the General Assembly of the
2 Commonwealth of Kentucky:
3 Section 1. The members of the House of Representatives encourage the
4 Kentucky Department for Public Health, in conjunction with the Kentucky Office of
5 Drug Control Policy, to issue a public statement to increase awareness in the
6 Commonwealth on the potential harm of consuming 7-hydroxymitragynine products.
7 Section 2. The Clerk of the House of Representatives is directed to transmit a
8 copy of this Resolution to the Kentucky Department for Public Health, the Kentucky
9 Office of Drug Control Policy, and the Governor.
Page 2 of 2
XXXX 3/12/2025 7:15 PM Jacketed
[DELETED:   2  J A R e t K D f P H i c t i a i t C o t p h o c 7 h W h b o w b t t s r i t b a o d W t W b W a t t U S F a D A 7 h m p c o e i s n a W W f c h d t t s 7 h h W c o 7 c l t a i u o o o W t W p N]
[DELETED:   2  J B i r b t H o R o t G A o t C S 1   T m o t H o R e t K D f P H i c w t K O o D C P t i a p s t i a i t C S c o t R t t K D f P H t K O]


================================================================================

Raw Text:
UNOFFICIAL COPY 25 RS BR 2025
1 A RESOLUTION encouraging the Kentucky Department for Public Health, in
2 conjunction with the Kentucky Office of Drug Control Policy, to issue a public statement
3 to increase awareness in the Commonwealth on the potential harm of consuming 7-
4 hydroxymitragynine products.
5 WHEREAS, kratom contains two main chemical compounds, mitragynine and 7-
6 hydroyxmitragynine, both of which bind to the same receptors in the brain as opioid
7 drugs such as codeine; and
8 WHEREAS, mitragynine is naturally present in kratom in much higher quantities
9 than 7-hydroxymitragynine; and
10 WHEREAS, 7-hydroxymitragynine is a terpenoid indole alkaloid that acts on the
11 brain’s opioid receptors; and
12 WHEREAS, according to the United States Food and Drug Administration, 7-
13 hydroxymitragynine may produce classic opioid-related effects including sedation,
14 nausea and vomiting, physical dependence and withdrawals, and respiratory depression;
15 and
16 WHEREAS, 7-hydroxymitragynine is an addictive substance; and
17 WHEREAS, food chemists have developed techniques to synthesize 7-
18 hydroxymitragynine from mitragynine allowing the artificial increase in the levels of 7-
19 hydroxymitragynine in kratom products; and
20 WHEREAS, according to a study published in the Addiction Biology Journal, the
21 consumption of 7-hydroxymitragynine can lead to an increased utilization of other
22 opioids including morphine; and
23 WHEREAS, the analgesic properties of 7-hydroxymitragynine are 13 times greater
24 than morphine; and
25 WHEREAS, there are companies marketing products labeled as kratom that may
26 primarily contain the more potent synthetic product called 7-hydroxmitragynine;
27 NOW, THEREFORE,
Page 1 of 2
XXXX 3/12/2025 7:15 PM Jacketed

UNOFFICIAL COPY 25 RS BR 2025
1 Be it resolved by the House of Representatives of the General Assembly of the
2 Commonwealth of Kentucky:
3 Section 1. The members of the House of Representatives encourage the
4 Kentucky Department for Public Health, in conjunction with the Kentucky Office of
5 Drug Control Policy, to issue a public statement to increase awareness in the
6 Commonwealth on the potential harm of consuming 7-hydroxymitragynine products.
7 Section 2. The Clerk of the House of Representatives is directed to transmit a
8 copy of this Resolution to the Kentucky Department for Public Health, the Kentucky
9 Office of Drug Control Policy, and the Governor.
Page 2 of 2
XXXX 3/12/2025 7:15 PM Jacketed

[DELETED:   2  J A R e t K D f P H i c t i a i t C o t p h o c 7 h W h b o w b t t s r i t b a o d W t W b W a t t U S F a D A 7 h m p c o e i s n a W W f c h d t t s 7 h h W c o 7 c l t a i u o o o W t W p N]
[DELETED:   2  J B i r b t H o R o t G A o t C S 1   T m o t H o R e t K D f P H i c w t K O o D C P t i a p s t i a i t C S c o t R t t K D f P H t K O]